Gilli M, Comas A, Garcia-Garcia M, et al. Comorbidity between common mental disorders and chronic somatic diseases in primary care. Gen Hosp Psychiatry 2010; 32: 240–245.
Menear M, Doré I, Cloutier AM, et al. Chronic physical comorbidity burden and the quality of depression treatment in primary care: A systematic review. J Psychosom Res 2015 Jan [cyt.13.03.2015]. doi: 10.1016/j.jpsychores.2015.01.001.
Egede LE . Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability. Gen Hosp Psychiatry 2007; 29: 409–416.
Cepuch G, Wojtas K, Zych B, et al. Assessment of emotional state of psoriasis patients and the degree of acceptance of the disease.Fam Med Prim Care Rev 2014; 16(2): 85–87.
Roest AM, Zuidersma M, de Jonge P. Myocardial infarction and generalized anxiety disorder: 10-year follow-up. Br J Psychiatry 2012; 200: 324–329.
Majkowicz M. Praktyczna ocena efektywności opieki paliatywnej – wybrane techniki badawcze. W: De Walden-Gałuszko K,
Majkowicz M, red. Ocena jakości opieki paliatywnej w teorii i praktyce. Gdańsk: Gdański Uniwersytet Medyczny; 2000: 21–42.
Bayat J, Alishiri GH, Salimzadeh A, et al. Symptoms of anxiety and depression: a comparison among patients with different chronic conditions. Res Med Sci 2011; 16: 1441–1447.
Geenen R, Newman S, Phil D, et al. Psychological interventions for patients with rheumatic diseases and anxiety or depression.Best Prac Res Clin Rheumatol 2012; 26: 305–319.
Janiszewska J, Lichodziejewska-Niemierko M, Gołębiewska J, et al. Determinants of anxiety in patients with advanced somatic disease: differences and similarities between patients undergoing renal replacement therapies and patients suffering from cancer.Int Urol Nephrol 2013; 45: 1379–1387.
Nowicka-Sauer K, Czuszyńska Z, Majkowicz M, et al. Neuropsychological assessment in mixed connective tissue disease:comparison with systemic lupus erythematosus. Lupus 2012; 9: 927–933.
Johnston M, Pollard B, Hennessey P. Construct validation of Hospital Anxiety and Depression Scale with clinical populations.J Psychosom Res 2000; 48: 579–584.
Broomfield NM, Quinn TJ, Abdul-Rahim AH, et al. Depression and anxiety symptoms post-stroke/TIA : prevalence and associations in cross-sectional data from a regional stroke registry. BMC Neurology 2014; 14: 198.
Szyguła-Jurkiewicz B, Szymik M, Mrozowska B, i wsp. Psychologiczne uwarunkowania i konsekwencje ostrego zawału serca.Leki psychotropowe u chorych po ostrym zawale serca. Chor Serca Naczyń 2011; 8: 62–69.
Herrmann C. International experiences with the Hospital Anxiety and Depression Scale: a review of validation data and clinical results. J Psychosom Res 1997; 42: 17–41.
Haddad M, Walters P, Phillips R, et al. Detecting depression in patients with coronary heart disease: a diagnostic evaluation of the PHQ-9 and HADS in primary care. Findings From the UPBEAT -UK Study. PlosOne 2013; 810: e78493.
Bjelland I, Dahl AA , Haug TT , et al. The validity of the Hospital Anxiety and Depression Scale an updated literature review.J Psychosom Res 2002; 52: 69–77.
Kroenke K, Spitzer RL , Williams JBW , et al. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.Ann Int Med 2007; 5: 317-325.
Nowicka-Sauer K, Cwaliński T, Pietrzykowska M, i wsp. Badania przesiewowe w kierunku zaburzeń psychicznych w populacji wiejskiej prowadzone w ramach akcji profilaktycznej. Fam Med Prim Care Rev 2014; 16: 143–145.
Spitzer RL , Kroenke K, Williams JB. Validation and utility of a self-report version of PRI ME-MD: the PHQ primary care study.
Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999; 282: 1734–1744.
Scott KM, Bruffaerts R, Tsang A, et al. Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health Surveys. J Affect Disord 2007; 103: 113–120.